Type 2 Diabetes (I8F-MC-GPGM)

Efficacy and safety of LY3298176 once weekly versus Insulin Glargine in patients with Type 2 Diabetes and increased cardiovascular risk.

Register Today!

Trial Information

Start DateAugust 2019
End Date2021
Trail Duration1 Year
Number of Visits26
Lead CRCAdam Pawluch
StatusCompleted Trial

For additional information on this trial contact: